98-23200. Intent to Grant Exclusive Patent License; Novavax Inc.

[Federal Register Volume 63, Number 167 (Friday, August 28, 1998)]
[Notices]
[Page 46004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-23200]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent to Grant Exclusive Patent License; Novavax Inc.

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Army hereby gives notice of its intent 
to grant to Novavax Inc., a revocable, nonassignable, exclusive license 
in the United States to practice the Government owned invention 
described in U.S. Patent No. 5,453,271, entitled ``Vaccine against 
ricin toxin,'' issued September 26, 1995. Anyone wishing to object to 
the grant of this license has 60 days from the date of this notice to 
file written objections along with supporting evidence, if any. Written 
objections may be filed with the Office of the Command Judge Advocate, 
U.S. Army Medical Research and Materiel Command, 504 Scott Street, Fort 
Detrick, Maryland, 21702-5012, ATTN: MCMR-JA.

FOR FURTHER INFORMATION CONTACT: Elizabeth Arwine, Attorney Advisor, 
[phone] or fax [phone].

SUPPLEMENTARY INFORMATION: None.
Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 98-23200 Filed 8-27-98; 8:45 am]
BILLING CODE 3710-08-M